By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

BioInvent 

Ideon Science and Technology Park
Sölvegatan 41
Lund    S-223 70  Sweden
Phone: 46-46-286-8550 Fax: 46-46-211-0806


SEARCH JOBS


Industry
Pharmaceutical

Segment
Drug Discovery





Company News
BioInvent (BOVNF) Confirms Clinical Strategy For BI-505 And Plans To Conduct Phase IIa Trial In Multiple Myeloma Post-Stem Cell Transplant Patients In The U.S. 3/19/2015 11:20:29 AM
BioInvent (BOVNF) Announces Plan To Initiate Clinical Development Of TB-403 In Pediatric Cancer Together With ThromboGenics Ltd. (THR.BR) 3/17/2015 11:04:25 AM
BioInvent (BOVNF) Financial Statement 1 January – 31 December 2014 2/18/2015 1:47:36 PM
BioInvent (BOVNF) Appoints Head Of Clinical Development 1/22/2015 12:32:55 PM
BioInvent (BOVNF)’s Bi-1206 Antibody To Enter Collaborative Phase 1/2 Trial Funded And Conducted By Cancer Research UK, CRT And LLR 1/20/2015 11:08:09 AM
BioInvent (BOVNF) Interim Report 1 January – 30 September 2014 10/23/2014 11:54:16 AM
BioInvent (BOVNF) Receives Another Milestone Payment From Bayer In Connection With Start Of A Phase I Trial 9/11/2014 11:28:42 AM
BioInvent (BOVNF) Interim Report 1 January – 30 June 2014 7/24/2014 11:17:18 AM
BioInvent (BOVNF) Has Received Milestones From Bayer Pharma S.A. (TEVA) And Servier 7/7/2014 11:57:11 AM
BioInvent (BOVNF) Granted U.S. Patent For BI-505 And Apoptosis-Inducing ICAM-1 Antibodies 6/24/2014 10:30:05 AM
12345678910...
//-->